Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Dedicated

- PMLiVE

Vynamic promotes Gemma Pfister to head of life sciences for Europe

Pfister has most recently been serving as senior executive and London hub lead at the company

- PMLiVE

VML and Definitive Healthcare announce partnership to transform key opinion leader management

The partnership offers a solution to streamline engagement between pharmaceutical companies and KOLs to help increase the value of the clinical collaborations and conversations

- PMLiVE

PM Society Digital Awards 2024 – open for entries

The event is held annually in September at The Brewery in London

- PMLiVE

The risk of replicating social bias in synthetic patient data – The need for human intelligence partnered with AI

Authored by Paul Reed and Anabelle Gall

Research Partnership

Neurodiversity-celebration

Creating an open and inclusive workplace drives innovation

We know that inclusion drives innovation. It’s why we’ve built DE&I into the DNA of our business. Find out how we're working to become a more open and inclusive employer.

Mednet Group

- PMLiVE

Mastering Asynchronous Meetings: Open-Ended Questions – Impetus Digital Tip 1

Unlock the potential of asynchronous virtual meetings with the first tip from our "Top 10 Tips for Optimizing Asynchronous Virtual Meetings".

Impetus Digital

- PMLiVE

A new campaign to welcome and celebrate neurodiversity across the UK healthcare communications industry

THINKING DIFFERENT This Neurodiversity Celebration Week (18 to 22 March) the Healthcare Communications Association (HCA), Fox&Cat, and The ADHD Foundation have joined forces to launch a new campaign to help...

Fox&Cat

Meet us at ISPOR

Mtech Access are exhibiting at ISPOR in the US

After many years attending ISPOR Europe, Mtech Access are excited to be attending the Global ISPOR conference May 5-8. Mtech Access are inviting ISPOR delegates to come by stand 125...

Mtech Access

- PMLiVE

Bristol Myers Squibb announces EC approval for multiple myeloma therapy Abecma

Approximately 50,000 cases of the blood cancer are diagnosed in Europe every year

- PMLiVE

Takeda’s HyQvia receives MHRA approval for rare neurological disorder CIDP

The therapy offers patients with CIDP a typical dosing interval of four weeks

- PMLiVE

Gates Medical Research Institute initiates phase 3 study of tuberculosis vaccine candidate

According to WHO, the infectious disease was estimated to affect 10.6 million people in 2022

- PMLiVE

Researchers reveal imaging technology could help diagnose and treat bowel cancer

Affecting over 250,000 people, bowel cancer is the fourth most common cancer in the UK

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links